Splenectomy in children with chronic ITP: Long-term efficacy and relation between its outcome and responses to previous treatments

Pediatric Blood and Cancer

Volumn 47, Issue 5 SUPPL., 2006, Pages 742-745

  Ramenghi, Ugo ^a,h   Amendola, Giovanni ^b   Farinasso, Loredana ^a   Giordano, Paola ^c   Loffredo, Giuseppe ^d   Nobili, Bruno ^e   Perrotta, Silverio ^e   Russo, Giovanna ^f   Zecca, Marco ^g  

^a UNIVERSITY OF TURIN   (Italy)

^b Umberto I Hospital   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d Pausilipon Hospital   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

^f UNIVERSITY OF CATANIA   (Italy)

^g FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^h Divisione di Ematologia   (Italy)

Author keywords

Immunoglobulins; Splenectomy; Thrombocytopenic purpura

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BENZATHINE PENICILLIN; CEFOTAXIME; DEXAMETHASONE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN; MENINGOCOCCUS VACCINE; METHYLPREDNISOLONE; PENICILLIN G; PNEUMOCOCCUS VACCINE; PREDNISONE; RHESUS D ANTIBODY; STEROID;

ADOLESCENT; ANTIBIOTIC PROPHYLAXIS; CHILD; CUSHING SYNDROME; ELECTIVE SURGERY; FEMALE; HEADACHE; HEMOLYSIS; HUMAN; HUMAN CELL; HYPERTENSION; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; REVIEW; SPLENECTOMY; THROMBOCYTE COUNT; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; ISOANTIBODIES; MALE; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; QUALITY OF LIFE; RETROSPECTIVE STUDIES; SPLENECTOMY; TIME FACTORS; TREATMENT OUTCOME;

EID: 33748491904     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20978     Document Type: Review

References (20)

1. Schultz Beardsley D, Nathan DG. Platelet abnormalities in infancy and childhood. In: Nathan DG, Orkin SH, editors. Nathan and Oski's hematology of infancy and childhood. Philadelphia: WB Saunders; 1998. 1585 p.
2. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura: A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
3. De Mattia D, Del Principe D, Del Vecchio GC, et al., The AIEOP ITP Study Group. Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Haematologica 2000;85:420-424.
4. Tarantino MD. Treatments options for chronic immune (idiopathic) thrombocytopenia purpura in children. Semin Hematol 2000;37:35-41.
5. Blanchette V. Childhood chronic thrombocytopenic purpura (ITP). Blood Rev 2002;16:23-26.
6. Law C, Marcaccio M, Tam P, et al. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 1997;336:1494-1498.
7. Schneider P, Wehmeier A, Schneider W. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 1997;337:1087-1088.
8. Fabris F, Cordiano I, Girolami A. High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med 1997;337:1088-1089.
9. Kondo H, Imamura T. High-dose intravenous immune globulin and the response to splenectomy monitoring with platelet-associated IgG in patients with idiopathic thrombocytopenic purpura. Eur J Haematol 1998;61:213-215.
10. Ruivard M, Caulier MT, Vantelon JM, et al. The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura. Br J Haematol 1999;105:1130-1132.
11. Hemmila MR, Foley DS, Castle VP, et al. The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin. J Pediatr Surg 2000;35:967-971.
12. Bussel JB, Kaufmann CP, Ware RE, et al. Do the acute platelet responses of patients with immune thrombocytopenic purpura (ITP) to IV anti-D and to IV gammaglobulin predict response to subsequent splenectomy? Am J Hematol 2001;67:27-33.
13. Choi CW, Kim BS, Seo JH, et al. Response to high-dose intravenous immune globulin as a valuable factor predicting the effect of splenectomy in chronic idiopathic thrombocytopenic purpura patients. Am J Hematol 2001;66:197-202.
14. Radaelli F, Faccini P, Goldaniga M, et al. Factors predicting response to splenectomy in adult patients with, idiopathic thrombocytopenic purpura. Haematologica 2000;85:1040-1044.
15. Holt D, Brown J, Terrill K, et al. Response to intravenous immunoglobulin predicts splenectomy response in children with immune thrombocytopenic purpura. Pediatrics 2003;111:87-90.
16. Waghorn DJ. Overwhelming infection in asplenic patients: Current best practice preventive measures are not being followed. J Clin Pathol 2001;54:214-218.
17. Working Party of the British Committee for Standards in Haematology Clinical Haematology Task Force. Guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen. Br Med J 1996;312:430-434.
18. Wang J, Wiley JM, Luddy R, et al. Chronic immune thrombocytopenic purpura in children: Assessment of rituximab treatment. J Pediatr 2005;146:217-221.
19. Bennett CM, Rogers ZR, Kinnamon DD, et al. Prospective phase I/II study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. Blood 2006;107:2639-2642.
20. Parodi E, Perrotta S, Nobili B, et al. Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic ITP: Efficacy and safety of treatment. Int J Haematol (in press).